News and Information

Investor

2026-01-13

Leading the Peptide Pipeline: Aoxiang Pharmaceutical Deeply Engages in Discussions on Reaction Safety Risk Assessment, Jointly Mapping Out the Industry’s Blueprint

In recent years, Aoxiang Pharmaceutical has, while maintaining its core strengths in active pharmaceutical ingredients, steadfastly implemented a “transformation and upgrading” strategy, prioritizing the research and development of peptide drugs, oligonucleotides, and synthetic biology technologies.

View Details

2024-06-29

Firefighting Competition

Zhejiang AUSUN Pharmaceutical Co., Ltd. held the 2024 Safety Production Month Firefighting Skills Competition.

View Details

Safety Month Knowledge Contest

To firmly establish the concept of safe development, enhance safety awareness

View Details >>

21

2024/06